Press Release Archive
-
Steering Drivers In The Right Direction, “Healthy Vision™ With Dr. Val Jones” Radio Show Offers Information, Advice About Driving In The DarkEnd of Daylight Savings Time means fewer hours of daylight; Experts talk about what happens to your eyes and on the road when it gets dark
-
Supplemental New Drug Application Submitted To FDA For NUCYNTA® ER (Tapentadol) Extended-Release Tablets For Diabetic Peripheral Neuropathic Pain
-
Ethicon Endo-Surgery Showcases Innovative “Learning Journey,” Procedure-Focused Educational Presentations and Key Product Innovations at the American College of Surgeons (ACS) ConferenceFirst-of-Its-Kind EESeducation.com Web Resource Offers Customized Learning Pathways for Surgeons, Residents, Nurses and Other Healthcare Professionals, Reinforcing EES’ Ongoing Commitment to Advancing ...
-
Johnson & Johnson Announces Fourth-Quarter 2011 Quarterly Dividend
-
STELARA® (Ustekinumab) Is Effective, Well-Tolerated And Improves Quality Of Life In Patients With Moderate To Severe Plaque Psoriasis Inadequately Responsive To Methotrexate[1,2]NEW DATA PRESENTED AT EADV
-
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
-
Ethicon Endo-Surgery Showcases Innovative “Learning Journey,” Procedure-Focused Educational Presentations and Key Product Innovations at the American College of Surgeons (ACS) ConferenceFirst-of-Its-Kind EESeducation.com Web Resource Offers Customized Learning Pathways for Surgeons, Residents, Nurses and Other Healthcare Professionals, Reinforcing EES’ Ongoing Commitment to Advancing ...
-
New Survey Reveals Americans Want Better Access To and Understanding of Blood Test ResultsOrtho Clinical Diagnostics and the National Association of Chronic Disease Directors Launch “Know Your Numbers” Educational Campaign in Conjunction with National Health Literacy Month
-
Johnson & Johnson Reports 2011 Third-Quarter ResultsSales of $16.0 Billion increased 6.8% Versus 2010 Third-Quarter; Third Quarter EPS was $1.15Excluding Special Items, 2011 Third-Quarter EPS of $1.24, increased 0.8%*
-
ASP Recognizes 25th Annual International Infection Prevention Week in Quest to Protect Lives against Infection